Advertisement

ASO Author Reflections: Tumor-Infiltrating NETs are New Biomarkers to Predict Postsurgical Survival for Patients with Pancreatic Ductal Adenocarcinoma

  • Wei Jin
  • Hua-Xiang Xu
  • Xian-Jun YuEmail author
  • Liang LiuEmail author
ASO Author Reflections

Notes

Disclosures

The authors have no conflicts of interest to disclose.

References

  1. 1.
    Kamisawa T, Wood LD, Itoi T, Takaori K. Pancreatic cancer. Lancet. 2016;10039:73–85.CrossRefGoogle Scholar
  2. 2.
    Wang WQ, Liu L, Xu HX, et al. Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma. Br J Surg. 2016;9:1189–99.CrossRefGoogle Scholar
  3. 3.
    Pulze L, Bassani B, Gini E, et al. Net amyloidogenic backbone in human activated neutrophils. Clin Exp Immunol. 2016;3:469–79.CrossRefGoogle Scholar
  4. 4.
    Jin W, Xu H-X, Zhang S-R, et al. Tumor-infiltrating NETs predict postsurgical survival in patients with pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2018.  https://doi.org/10.1245/s10434-018-6941-4.Google Scholar

Copyright information

© Society of Surgical Oncology 2019

Authors and Affiliations

  1. 1.Department of Pancreatic SurgeryFudan University Shanghai Cancer CenterShanghaiChina
  2. 2.Department of Oncology, Shanghai Medical CollegeFudan UniversityShanghaiChina
  3. 3.Shanghai Pancreatic Cancer InstituteShanghaiChina
  4. 4.Pancreatic Cancer InstituteFudan UniversityShanghaiChina
  5. 5.Department of Immunology and Microbiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of EducationShanghai Jiao Tong University School of Medicine (SJTU-SM), Shanghai Institute of ImmunologyShanghaiChina

Personalised recommendations